IL ‐6 Signalling to Responding T Cells Is Key to Calcitonin Gene‐Related Peptide‐Exposed Endothelial Cell Enhancement of Th17 Immunity During Langerhans Cell Antigen Presentation
Immunology · 2025
DOI: 10.1111/imm.13892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Wanhong Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Interleukin-6, Th17 Cells, Langerhans Cells, Calcitonin Gene-Related Peptide. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Seth Sprague Educational and Charitable Foundation, NCATS NIH HHS, Pfizer.
Abstract (Originalsprache)
Calcitonin gene‐related peptide (CGRP) biases Langerhans cell (LC) Ag presentation to CD4 + T cells towards Th17‐type immunity through actions on endothelial cells (ECs). We now report further evidence that IL‐6 signalling at responding T cells mediates this effect. This CGRP effect was absent with ECs from IL‐6 KO mice. Exposure of LCs, but not T cells, to IL‐6 enhanced IL‐6 and IL‐17A production and reduced IFN‐γ in the T‐cell response. Pretreatment of LCs with IL‐6 receptor α‐chain (IL‐6Rα) antibodies prior to IL‐6 exposure significantly inhibited these responses. However, T‐cell pretreatment with an IL‐6/IL‐6Rα chimera mimicked the effect of IL‐6 pretreatment of LCs on T‐cell responses. When this experiment was performed in the presence of the ADAM17 and ADAM10 inhibitor TAPI‐1 during LC pretreatment of LCs and during the Ag presentation culture, release of soluble IL‐6Rα chains into the medium was very significantly reduced, but this did not affect levels of T‐cell cytokine release. Interestingly, LC exposure to IL‐6 significantly increased LC IL‐6 expression. Furthermore, pretreatment of T cells with antibodies against the IL‐6 receptor β‐chain significantly inhibited the IL‐6 effect. CGRP may stimulate ECs in lymphatics and/or lymph nodes to produce IL‐6 which likely results in migrating LCs nonclassically presenting IL‐6. Furthermore, we found that IL‐6 induces IL‐6 production by LCs, suggesting an autocrine amplification pathway for this effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.
- Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA.
- Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.
ORCID-Profile: Richard D Granstein
Förderung
- Seth Sprague Educational and Charitable Foundation
- NCATS NIH HHS
- Pfizer
- Filomen M. D'Agostino Foundation
- National Center for Advancing Translational Sciences
Zitieren
APA
Ding, W., Moattari, C., Stohl, L. L., Wagner, J. A., Zhou, X. K., & Granstein, R. D. (2025). IL ‐6 Signalling to Responding T Cells Is Key to Calcitonin Gene‐Related Peptide‐Exposed Endothelial Cell Enhancement of Th17 Immunity During Langerhans Cell Antigen Presentation. Immunology. https://doi.org/10.1111/imm.13892
Vancouver
Ding W, Moattari C, Stohl LL, Wagner JA, Zhou XK, Granstein RD. IL ‐6 Signalling to Responding T Cells Is Key to Calcitonin Gene‐Related Peptide‐Exposed Endothelial Cell Enhancement of Th17 Immunity During Langerhans Cell Antigen Presentation. Immunology. 2025. doi:10.1111/imm.13892
BibTeX
@article{Ding2025,
author = {Ding, Wanhong and Moattari, Cameron and Stohl, Lori L and Wagner, John A and Zhou, Xi K and Granstein, Richard D},
title = {IL ‐6 Signalling to Responding T Cells Is Key to Calcitonin Gene‐Related Peptide‐Exposed Endothelial Cell Enhancement of Th17 Immunity During Langerhans Cell Antigen Presentation},
journal = {Immunology},
year = {2025},
doi = {10.1111/imm.13892}
}
EUVIMED